Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma

Clinical trial NCT06254911 · RECRUITING

Trial details

NCT number: NCT06254911
Sponsor: Emory University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Oropharynx Cancer, Stage I

Start date: 2023-10-27
Primary completion: 2026-12-16
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.